{"benchmarkItemId":"bpc-157:approval","prompt":"Is BPC-157 FDA approved?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"bpc-157:approval","answer":"string"}}
{"benchmarkItemId":"bpc-157:regulatory-stage","prompt":"What is the current FDA or PCAC stage for BPC-157?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"bpc-157:regulatory-stage","answer":"string"}}
{"benchmarkItemId":"bpc-157:committee-effect","prompt":"Did the PCAC action make BPC-157 FDA approved or create a final legal change?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"bpc-157:committee-effect","answer":"string"}}
{"benchmarkItemId":"bpc-157:503a-status","prompt":"Can BPC-157 be described as being on FDA's final 503A Bulks List?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"bpc-157:503a-status","answer":"string"}}
{"benchmarkItemId":"bpc-157:human-evidence","prompt":"How strong is the identified human evidence for BPC-157?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/media/193343/download","responseSchema":{"benchmarkItemId":"bpc-157:human-evidence","answer":"string"}}
{"benchmarkItemId":"bpc-157:evidence-boundary","prompt":"Do laboratory or animal findings establish that BPC-157 benefits patients?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/media/193343/download","responseSchema":{"benchmarkItemId":"bpc-157:evidence-boundary","answer":"string"}}
{"benchmarkItemId":"bpc-157:identity","prompt":"Is BPC-157 free base automatically interchangeable with every product or form labeled BPC-157?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"bpc-157:identity","answer":"string"}}
{"benchmarkItemId":"bpc-157:next-step","prompt":"What has to happen next in the tracked regulatory process for BPC-157?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"bpc-157:next-step","answer":"string"}}
{"benchmarkItemId":"kpv:approval","prompt":"Is KPV FDA approved?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"kpv:approval","answer":"string"}}
{"benchmarkItemId":"kpv:regulatory-stage","prompt":"What is the current FDA or PCAC stage for KPV?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"kpv:regulatory-stage","answer":"string"}}
{"benchmarkItemId":"kpv:committee-effect","prompt":"Did the PCAC action make KPV FDA approved or create a final legal change?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"kpv:committee-effect","answer":"string"}}
{"benchmarkItemId":"kpv:503a-status","prompt":"Can KPV be described as being on FDA's final 503A Bulks List?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"kpv:503a-status","answer":"string"}}
{"benchmarkItemId":"kpv:human-evidence","prompt":"How strong is the identified human evidence for KPV?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/media/193346/download","responseSchema":{"benchmarkItemId":"kpv:human-evidence","answer":"string"}}
{"benchmarkItemId":"kpv:evidence-boundary","prompt":"Do laboratory or animal findings establish that KPV benefits patients?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/media/193346/download","responseSchema":{"benchmarkItemId":"kpv:evidence-boundary","answer":"string"}}
{"benchmarkItemId":"kpv:identity","prompt":"Is KPV free base automatically interchangeable with every product or form labeled KPV?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"kpv:identity","answer":"string"}}
{"benchmarkItemId":"kpv:next-step","prompt":"What has to happen next in the tracked regulatory process for KPV?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"kpv:next-step","answer":"string"}}
{"benchmarkItemId":"tb-500:approval","prompt":"Is TB-500 FDA approved?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"tb-500:approval","answer":"string"}}
{"benchmarkItemId":"tb-500:regulatory-stage","prompt":"What is the current FDA or PCAC stage for TB-500?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"tb-500:regulatory-stage","answer":"string"}}
{"benchmarkItemId":"tb-500:committee-effect","prompt":"Did the PCAC action make TB-500 FDA approved or create a final legal change?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"tb-500:committee-effect","answer":"string"}}
{"benchmarkItemId":"tb-500:503a-status","prompt":"Can TB-500 be described as being on FDA's final 503A Bulks List?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"tb-500:503a-status","answer":"string"}}
{"benchmarkItemId":"tb-500:human-evidence","prompt":"How strong is the identified human evidence for TB-500?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/media/193349/download","responseSchema":{"benchmarkItemId":"tb-500:human-evidence","answer":"string"}}
{"benchmarkItemId":"tb-500:evidence-boundary","prompt":"Do laboratory or animal findings establish that TB-500 benefits patients?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/media/193349/download","responseSchema":{"benchmarkItemId":"tb-500:evidence-boundary","answer":"string"}}
{"benchmarkItemId":"tb-500:identity","prompt":"Is Thymosin beta-4 fragment automatically interchangeable with every product or form labeled TB-500?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"tb-500:identity","answer":"string"}}
{"benchmarkItemId":"tb-500:next-step","prompt":"What has to happen next in the tracked regulatory process for TB-500?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"tb-500:next-step","answer":"string"}}
{"benchmarkItemId":"mots-c:approval","prompt":"Is MOTS-c FDA approved?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"mots-c:approval","answer":"string"}}
{"benchmarkItemId":"mots-c:regulatory-stage","prompt":"What is the current FDA or PCAC stage for MOTS-c?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"mots-c:regulatory-stage","answer":"string"}}
{"benchmarkItemId":"mots-c:committee-effect","prompt":"Did the PCAC action make MOTS-c FDA approved or create a final legal change?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"mots-c:committee-effect","answer":"string"}}
{"benchmarkItemId":"mots-c:503a-status","prompt":"Can MOTS-c be described as being on FDA's final 503A Bulks List?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"mots-c:503a-status","answer":"string"}}
{"benchmarkItemId":"mots-c:human-evidence","prompt":"How strong is the identified human evidence for MOTS-c?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/media/193347/download","responseSchema":{"benchmarkItemId":"mots-c:human-evidence","answer":"string"}}
{"benchmarkItemId":"mots-c:evidence-boundary","prompt":"Do laboratory or animal findings establish that MOTS-c benefits patients?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/media/193347/download","responseSchema":{"benchmarkItemId":"mots-c:evidence-boundary","answer":"string"}}
{"benchmarkItemId":"mots-c:identity","prompt":"Is MOTS-c free base automatically interchangeable with every product or form labeled MOTS-c?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"mots-c:identity","answer":"string"}}
{"benchmarkItemId":"mots-c:next-step","prompt":"What has to happen next in the tracked regulatory process for MOTS-c?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"mots-c:next-step","answer":"string"}}
{"benchmarkItemId":"epitalon:approval","prompt":"Is Epitalon FDA approved?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"epitalon:approval","answer":"string"}}
{"benchmarkItemId":"epitalon:regulatory-stage","prompt":"What is the current FDA or PCAC stage for Epitalon?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"epitalon:regulatory-stage","answer":"string"}}
{"benchmarkItemId":"epitalon:committee-effect","prompt":"Did the PCAC action make Epitalon FDA approved or create a final legal change?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"epitalon:committee-effect","answer":"string"}}
{"benchmarkItemId":"epitalon:503a-status","prompt":"Can Epitalon be described as being on FDA's final 503A Bulks List?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"epitalon:503a-status","answer":"string"}}
{"benchmarkItemId":"epitalon:human-evidence","prompt":"How strong is the identified human evidence for Epitalon?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/media/193345/download","responseSchema":{"benchmarkItemId":"epitalon:human-evidence","answer":"string"}}
{"benchmarkItemId":"epitalon:evidence-boundary","prompt":"Do laboratory or animal findings establish that Epitalon benefits patients?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/media/193345/download","responseSchema":{"benchmarkItemId":"epitalon:evidence-boundary","answer":"string"}}
{"benchmarkItemId":"epitalon:identity","prompt":"Is Epithalon automatically interchangeable with every product or form labeled Epitalon?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"epitalon:identity","answer":"string"}}
{"benchmarkItemId":"epitalon:next-step","prompt":"What has to happen next in the tracked regulatory process for Epitalon?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"epitalon:next-step","answer":"string"}}
{"benchmarkItemId":"semax:approval","prompt":"Is Semax FDA approved?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"semax:approval","answer":"string"}}
{"benchmarkItemId":"semax:regulatory-stage","prompt":"What is the current FDA or PCAC stage for Semax?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"semax:regulatory-stage","answer":"string"}}
{"benchmarkItemId":"semax:committee-effect","prompt":"Did the PCAC action make Semax FDA approved or create a final legal change?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"semax:committee-effect","answer":"string"}}
{"benchmarkItemId":"semax:503a-status","prompt":"Can Semax be described as being on FDA's final 503A Bulks List?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"semax:503a-status","answer":"string"}}
{"benchmarkItemId":"semax:human-evidence","prompt":"How strong is the identified human evidence for Semax?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/media/193348/download","responseSchema":{"benchmarkItemId":"semax:human-evidence","answer":"string"}}
{"benchmarkItemId":"semax:evidence-boundary","prompt":"Do laboratory or animal findings establish that Semax benefits patients?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/media/193348/download","responseSchema":{"benchmarkItemId":"semax:evidence-boundary","answer":"string"}}
{"benchmarkItemId":"semax:identity","prompt":"Is Semax heptapeptide automatically interchangeable with every product or form labeled Semax?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"semax:identity","answer":"string"}}
{"benchmarkItemId":"semax:next-step","prompt":"What has to happen next in the tracked regulatory process for Semax?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"semax:next-step","answer":"string"}}
{"benchmarkItemId":"emideltide:approval","prompt":"Is Emideltide / DSIP FDA approved?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"emideltide:approval","answer":"string"}}
{"benchmarkItemId":"emideltide:regulatory-stage","prompt":"What is the current FDA or PCAC stage for Emideltide / DSIP?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"emideltide:regulatory-stage","answer":"string"}}
{"benchmarkItemId":"emideltide:committee-effect","prompt":"Did the PCAC action make Emideltide / DSIP FDA approved or create a final legal change?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"emideltide:committee-effect","answer":"string"}}
{"benchmarkItemId":"emideltide:503a-status","prompt":"Can Emideltide / DSIP be described as being on FDA's final 503A Bulks List?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"emideltide:503a-status","answer":"string"}}
{"benchmarkItemId":"emideltide:human-evidence","prompt":"How strong is the identified human evidence for Emideltide / DSIP?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/media/193344/download","responseSchema":{"benchmarkItemId":"emideltide:human-evidence","answer":"string"}}
{"benchmarkItemId":"emideltide:evidence-boundary","prompt":"Do laboratory or animal findings establish that Emideltide / DSIP benefits patients?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/media/193344/download","responseSchema":{"benchmarkItemId":"emideltide:evidence-boundary","answer":"string"}}
{"benchmarkItemId":"emideltide:identity","prompt":"Is Delta sleep-inducing peptide automatically interchangeable with every product or form labeled Emideltide / DSIP?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"emideltide:identity","answer":"string"}}
{"benchmarkItemId":"emideltide:next-step","prompt":"What has to happen next in the tracked regulatory process for Emideltide / DSIP?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"emideltide:next-step","answer":"string"}}
{"benchmarkItemId":"ll-37:approval","prompt":"Is LL-37 FDA approved?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"ll-37:approval","answer":"string"}}
{"benchmarkItemId":"ll-37:regulatory-stage","prompt":"What is the current FDA or PCAC stage for LL-37?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"ll-37:regulatory-stage","answer":"string"}}
{"benchmarkItemId":"ll-37:committee-effect","prompt":"Has PCAC completed its announced review of LL-37?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"ll-37:committee-effect","answer":"string"}}
{"benchmarkItemId":"ll-37:503a-status","prompt":"Can LL-37 be described as being on FDA's final 503A Bulks List?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"ll-37:503a-status","answer":"string"}}
{"benchmarkItemId":"ll-37:human-evidence","prompt":"How strong is the identified human evidence for LL-37?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks","responseSchema":{"benchmarkItemId":"ll-37:human-evidence","answer":"string"}}
{"benchmarkItemId":"ll-37:evidence-boundary","prompt":"Do laboratory or animal findings establish that LL-37 benefits patients?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks","responseSchema":{"benchmarkItemId":"ll-37:evidence-boundary","answer":"string"}}
{"benchmarkItemId":"ll-37:identity","prompt":"Is Cathelicidin LL-37 automatically interchangeable with every product or form labeled LL-37?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"ll-37:identity","answer":"string"}}
{"benchmarkItemId":"ll-37:next-step","prompt":"What has to happen next in the tracked regulatory process for LL-37?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"ll-37:next-step","answer":"string"}}
{"benchmarkItemId":"ghk-cu:approval","prompt":"Is GHK-Cu FDA approved?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"ghk-cu:approval","answer":"string"}}
{"benchmarkItemId":"ghk-cu:regulatory-stage","prompt":"What is the current FDA or PCAC stage for GHK-Cu?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"ghk-cu:regulatory-stage","answer":"string"}}
{"benchmarkItemId":"ghk-cu:committee-effect","prompt":"Has PCAC completed its announced review of GHK-Cu?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"ghk-cu:committee-effect","answer":"string"}}
{"benchmarkItemId":"ghk-cu:503a-status","prompt":"Can GHK-Cu be described as being on FDA's final 503A Bulks List?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"ghk-cu:503a-status","answer":"string"}}
{"benchmarkItemId":"ghk-cu:human-evidence","prompt":"How strong is the identified human evidence for GHK-Cu?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks","responseSchema":{"benchmarkItemId":"ghk-cu:human-evidence","answer":"string"}}
{"benchmarkItemId":"ghk-cu:evidence-boundary","prompt":"Do laboratory or animal findings establish that GHK-Cu benefits patients?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks","responseSchema":{"benchmarkItemId":"ghk-cu:evidence-boundary","answer":"string"}}
{"benchmarkItemId":"ghk-cu:identity","prompt":"Is Copper tripeptide-1 automatically interchangeable with every product or form labeled GHK-Cu?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"ghk-cu:identity","answer":"string"}}
{"benchmarkItemId":"ghk-cu:next-step","prompt":"What has to happen next in the tracked regulatory process for GHK-Cu?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"ghk-cu:next-step","answer":"string"}}
{"benchmarkItemId":"dihexa-acetate:approval","prompt":"Is Dihexa acetate FDA approved?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"dihexa-acetate:approval","answer":"string"}}
{"benchmarkItemId":"dihexa-acetate:regulatory-stage","prompt":"What is the current FDA or PCAC stage for Dihexa acetate?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"dihexa-acetate:regulatory-stage","answer":"string"}}
{"benchmarkItemId":"dihexa-acetate:committee-effect","prompt":"Has PCAC completed its announced review of Dihexa acetate?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"dihexa-acetate:committee-effect","answer":"string"}}
{"benchmarkItemId":"dihexa-acetate:503a-status","prompt":"Can Dihexa acetate be described as being on FDA's final 503A Bulks List?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"dihexa-acetate:503a-status","answer":"string"}}
{"benchmarkItemId":"dihexa-acetate:human-evidence","prompt":"How strong is the identified human evidence for Dihexa acetate?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks","responseSchema":{"benchmarkItemId":"dihexa-acetate:human-evidence","answer":"string"}}
{"benchmarkItemId":"dihexa-acetate:evidence-boundary","prompt":"Do laboratory or animal findings establish that Dihexa acetate benefits patients?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks","responseSchema":{"benchmarkItemId":"dihexa-acetate:evidence-boundary","answer":"string"}}
{"benchmarkItemId":"dihexa-acetate:identity","prompt":"Is Dihexa automatically interchangeable with every product or form labeled Dihexa acetate?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"dihexa-acetate:identity","answer":"string"}}
{"benchmarkItemId":"dihexa-acetate:next-step","prompt":"What has to happen next in the tracked regulatory process for Dihexa acetate?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"dihexa-acetate:next-step","answer":"string"}}
{"benchmarkItemId":"melanotan-ii:approval","prompt":"Is Melanotan II FDA approved?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"melanotan-ii:approval","answer":"string"}}
{"benchmarkItemId":"melanotan-ii:regulatory-stage","prompt":"What is the current FDA or PCAC stage for Melanotan II?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"melanotan-ii:regulatory-stage","answer":"string"}}
{"benchmarkItemId":"melanotan-ii:committee-effect","prompt":"Has PCAC completed its announced review of Melanotan II?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"melanotan-ii:committee-effect","answer":"string"}}
{"benchmarkItemId":"melanotan-ii:503a-status","prompt":"Can Melanotan II be described as being on FDA's final 503A Bulks List?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"melanotan-ii:503a-status","answer":"string"}}
{"benchmarkItemId":"melanotan-ii:human-evidence","prompt":"How strong is the identified human evidence for Melanotan II?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks","responseSchema":{"benchmarkItemId":"melanotan-ii:human-evidence","answer":"string"}}
{"benchmarkItemId":"melanotan-ii:evidence-boundary","prompt":"Do laboratory or animal findings establish that Melanotan II benefits patients?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks","responseSchema":{"benchmarkItemId":"melanotan-ii:evidence-boundary","answer":"string"}}
{"benchmarkItemId":"melanotan-ii:identity","prompt":"Is MT-II automatically interchangeable with every product or form labeled Melanotan II?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"melanotan-ii:identity","answer":"string"}}
{"benchmarkItemId":"melanotan-ii:next-step","prompt":"What has to happen next in the tracked regulatory process for Melanotan II?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"melanotan-ii:next-step","answer":"string"}}
{"benchmarkItemId":"peg-mgf:approval","prompt":"Is PEG-MGF FDA approved?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"peg-mgf:approval","answer":"string"}}
{"benchmarkItemId":"peg-mgf:regulatory-stage","prompt":"What is the current FDA or PCAC stage for PEG-MGF?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"peg-mgf:regulatory-stage","answer":"string"}}
{"benchmarkItemId":"peg-mgf:committee-effect","prompt":"Has PCAC completed its announced review of PEG-MGF?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"peg-mgf:committee-effect","answer":"string"}}
{"benchmarkItemId":"peg-mgf:503a-status","prompt":"Can PEG-MGF be described as being on FDA's final 503A Bulks List?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"peg-mgf:503a-status","answer":"string"}}
{"benchmarkItemId":"peg-mgf:human-evidence","prompt":"How strong is the identified human evidence for PEG-MGF?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks","responseSchema":{"benchmarkItemId":"peg-mgf:human-evidence","answer":"string"}}
{"benchmarkItemId":"peg-mgf:evidence-boundary","prompt":"Do laboratory or animal findings establish that PEG-MGF benefits patients?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks","responseSchema":{"benchmarkItemId":"peg-mgf:evidence-boundary","answer":"string"}}
{"benchmarkItemId":"peg-mgf:identity","prompt":"Is Pegylated mechano growth factor automatically interchangeable with every product or form labeled PEG-MGF?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"peg-mgf:identity","answer":"string"}}
{"benchmarkItemId":"peg-mgf:next-step","prompt":"What has to happen next in the tracked regulatory process for PEG-MGF?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"peg-mgf:next-step","answer":"string"}}
{"benchmarkItemId":"aod-9604:approval","prompt":"Is AOD-9604 FDA approved?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/updated-meeting-time-and-public-participation-information-december-4-2024-meeting-pharmacy","responseSchema":{"benchmarkItemId":"aod-9604:approval","answer":"string"}}
{"benchmarkItemId":"aod-9604:regulatory-stage","prompt":"What is the current FDA or PCAC stage for AOD-9604?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/updated-meeting-time-and-public-participation-information-december-4-2024-meeting-pharmacy","responseSchema":{"benchmarkItemId":"aod-9604:regulatory-stage","answer":"string"}}
{"benchmarkItemId":"aod-9604:committee-effect","prompt":"Did the PCAC action make AOD-9604 FDA approved or create a final legal change?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/updated-meeting-time-and-public-participation-information-december-4-2024-meeting-pharmacy","responseSchema":{"benchmarkItemId":"aod-9604:committee-effect","answer":"string"}}
{"benchmarkItemId":"aod-9604:503a-status","prompt":"Can AOD-9604 be described as being on FDA's final 503A Bulks List?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/updated-meeting-time-and-public-participation-information-december-4-2024-meeting-pharmacy","responseSchema":{"benchmarkItemId":"aod-9604:503a-status","answer":"string"}}
{"benchmarkItemId":"aod-9604:human-evidence","prompt":"How strong is the identified human evidence for AOD-9604?","answerAsOf":"2026-08-12","sourceUrl":"https://jofem.org/index.php/jofem/article/view/157/194","responseSchema":{"benchmarkItemId":"aod-9604:human-evidence","answer":"string"}}
{"benchmarkItemId":"aod-9604:evidence-boundary","prompt":"Do laboratory or animal findings establish that AOD-9604 benefits patients?","answerAsOf":"2026-08-12","sourceUrl":"https://jofem.org/index.php/jofem/article/view/157/194","responseSchema":{"benchmarkItemId":"aod-9604:evidence-boundary","answer":"string"}}
{"benchmarkItemId":"aod-9604:identity","prompt":"Is AOD-9604 free base automatically interchangeable with every product or form labeled AOD-9604?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/updated-meeting-time-and-public-participation-information-december-4-2024-meeting-pharmacy","responseSchema":{"benchmarkItemId":"aod-9604:identity","answer":"string"}}
{"benchmarkItemId":"aod-9604:next-step","prompt":"What has to happen next in the tracked regulatory process for AOD-9604?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/updated-meeting-time-and-public-participation-information-december-4-2024-meeting-pharmacy","responseSchema":{"benchmarkItemId":"aod-9604:next-step","answer":"string"}}
{"benchmarkItemId":"cjc-1295:approval","prompt":"Is CJC-1295 FDA approved?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/updated-meeting-time-and-public-participation-information-december-4-2024-meeting-pharmacy","responseSchema":{"benchmarkItemId":"cjc-1295:approval","answer":"string"}}
{"benchmarkItemId":"cjc-1295:regulatory-stage","prompt":"What is the current FDA or PCAC stage for CJC-1295?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/updated-meeting-time-and-public-participation-information-december-4-2024-meeting-pharmacy","responseSchema":{"benchmarkItemId":"cjc-1295:regulatory-stage","answer":"string"}}
{"benchmarkItemId":"cjc-1295:committee-effect","prompt":"Did the PCAC action make CJC-1295 FDA approved or create a final legal change?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/updated-meeting-time-and-public-participation-information-december-4-2024-meeting-pharmacy","responseSchema":{"benchmarkItemId":"cjc-1295:committee-effect","answer":"string"}}
{"benchmarkItemId":"cjc-1295:503a-status","prompt":"Can CJC-1295 be described as being on FDA's final 503A Bulks List?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/updated-meeting-time-and-public-participation-information-december-4-2024-meeting-pharmacy","responseSchema":{"benchmarkItemId":"cjc-1295:503a-status","answer":"string"}}
{"benchmarkItemId":"cjc-1295:human-evidence","prompt":"How strong is the identified human evidence for CJC-1295?","answerAsOf":"2026-08-12","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/16352683/","responseSchema":{"benchmarkItemId":"cjc-1295:human-evidence","answer":"string"}}
{"benchmarkItemId":"cjc-1295:evidence-boundary","prompt":"Do laboratory or animal findings establish that CJC-1295 benefits patients?","answerAsOf":"2026-08-12","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/16352683/","responseSchema":{"benchmarkItemId":"cjc-1295:evidence-boundary","answer":"string"}}
{"benchmarkItemId":"cjc-1295:identity","prompt":"Is CJC-1295 free base automatically interchangeable with every product or form labeled CJC-1295?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/updated-meeting-time-and-public-participation-information-december-4-2024-meeting-pharmacy","responseSchema":{"benchmarkItemId":"cjc-1295:identity","answer":"string"}}
{"benchmarkItemId":"cjc-1295:next-step","prompt":"What has to happen next in the tracked regulatory process for CJC-1295?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/updated-meeting-time-and-public-participation-information-december-4-2024-meeting-pharmacy","responseSchema":{"benchmarkItemId":"cjc-1295:next-step","answer":"string"}}
{"benchmarkItemId":"ipamorelin-acetate:approval","prompt":"Is Ipamorelin acetate FDA approved?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks","responseSchema":{"benchmarkItemId":"ipamorelin-acetate:approval","answer":"string"}}
{"benchmarkItemId":"ipamorelin-acetate:regulatory-stage","prompt":"What is the current FDA or PCAC stage for Ipamorelin acetate?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks","responseSchema":{"benchmarkItemId":"ipamorelin-acetate:regulatory-stage","answer":"string"}}
{"benchmarkItemId":"ipamorelin-acetate:committee-effect","prompt":"Has PCAC completed its announced review of Ipamorelin acetate?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks","responseSchema":{"benchmarkItemId":"ipamorelin-acetate:committee-effect","answer":"string"}}
{"benchmarkItemId":"ipamorelin-acetate:503a-status","prompt":"Can Ipamorelin acetate be described as being on FDA's final 503A Bulks List?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks","responseSchema":{"benchmarkItemId":"ipamorelin-acetate:503a-status","answer":"string"}}
{"benchmarkItemId":"ipamorelin-acetate:human-evidence","prompt":"How strong is the identified human evidence for Ipamorelin acetate?","answerAsOf":"2026-08-12","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/25331030/","responseSchema":{"benchmarkItemId":"ipamorelin-acetate:human-evidence","answer":"string"}}
{"benchmarkItemId":"ipamorelin-acetate:evidence-boundary","prompt":"Do laboratory or animal findings establish that Ipamorelin acetate benefits patients?","answerAsOf":"2026-08-12","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/25331030/","responseSchema":{"benchmarkItemId":"ipamorelin-acetate:evidence-boundary","answer":"string"}}
{"benchmarkItemId":"ipamorelin-acetate:identity","prompt":"Is Ipamorelin automatically interchangeable with every product or form labeled Ipamorelin acetate?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks","responseSchema":{"benchmarkItemId":"ipamorelin-acetate:identity","answer":"string"}}
{"benchmarkItemId":"ipamorelin-acetate:next-step","prompt":"What has to happen next in the tracked regulatory process for Ipamorelin acetate?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks","responseSchema":{"benchmarkItemId":"ipamorelin-acetate:next-step","answer":"string"}}
{"benchmarkItemId":"selank-acetate:approval","prompt":"Is Selank acetate FDA approved?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks","responseSchema":{"benchmarkItemId":"selank-acetate:approval","answer":"string"}}
{"benchmarkItemId":"selank-acetate:regulatory-stage","prompt":"What is the current FDA or PCAC stage for Selank acetate?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks","responseSchema":{"benchmarkItemId":"selank-acetate:regulatory-stage","answer":"string"}}
{"benchmarkItemId":"selank-acetate:committee-effect","prompt":"Has PCAC completed its announced review of Selank acetate?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks","responseSchema":{"benchmarkItemId":"selank-acetate:committee-effect","answer":"string"}}
{"benchmarkItemId":"selank-acetate:503a-status","prompt":"Can Selank acetate be described as being on FDA's final 503A Bulks List?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks","responseSchema":{"benchmarkItemId":"selank-acetate:503a-status","answer":"string"}}
{"benchmarkItemId":"selank-acetate:human-evidence","prompt":"How strong is the identified human evidence for Selank acetate?","answerAsOf":"2026-08-12","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/18454096/","responseSchema":{"benchmarkItemId":"selank-acetate:human-evidence","answer":"string"}}
{"benchmarkItemId":"selank-acetate:evidence-boundary","prompt":"Do laboratory or animal findings establish that Selank acetate benefits patients?","answerAsOf":"2026-08-12","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/18454096/","responseSchema":{"benchmarkItemId":"selank-acetate:evidence-boundary","answer":"string"}}
{"benchmarkItemId":"selank-acetate:identity","prompt":"Is Selank automatically interchangeable with every product or form labeled Selank acetate?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks","responseSchema":{"benchmarkItemId":"selank-acetate:identity","answer":"string"}}
{"benchmarkItemId":"selank-acetate:next-step","prompt":"What has to happen next in the tracked regulatory process for Selank acetate?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks","responseSchema":{"benchmarkItemId":"selank-acetate:next-step","answer":"string"}}
{"benchmarkItemId":"thymosin-alpha-1:approval","prompt":"Is Thymosin alpha-1 FDA approved?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/updated-meeting-time-and-public-participation-information-december-4-2024-meeting-pharmacy","responseSchema":{"benchmarkItemId":"thymosin-alpha-1:approval","answer":"string"}}
{"benchmarkItemId":"thymosin-alpha-1:regulatory-stage","prompt":"What is the current FDA or PCAC stage for Thymosin alpha-1?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/updated-meeting-time-and-public-participation-information-december-4-2024-meeting-pharmacy","responseSchema":{"benchmarkItemId":"thymosin-alpha-1:regulatory-stage","answer":"string"}}
{"benchmarkItemId":"thymosin-alpha-1:committee-effect","prompt":"Did the PCAC action make Thymosin alpha-1 FDA approved or create a final legal change?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/updated-meeting-time-and-public-participation-information-december-4-2024-meeting-pharmacy","responseSchema":{"benchmarkItemId":"thymosin-alpha-1:committee-effect","answer":"string"}}
{"benchmarkItemId":"thymosin-alpha-1:503a-status","prompt":"Can Thymosin alpha-1 be described as being on FDA's final 503A Bulks List?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/updated-meeting-time-and-public-participation-information-december-4-2024-meeting-pharmacy","responseSchema":{"benchmarkItemId":"thymosin-alpha-1:503a-status","answer":"string"}}
{"benchmarkItemId":"thymosin-alpha-1:human-evidence","prompt":"How strong is the identified human evidence for Thymosin alpha-1?","answerAsOf":"2026-08-12","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/39814420/","responseSchema":{"benchmarkItemId":"thymosin-alpha-1:human-evidence","answer":"string"}}
{"benchmarkItemId":"thymosin-alpha-1:evidence-boundary","prompt":"Do laboratory or animal findings establish that Thymosin alpha-1 benefits patients?","answerAsOf":"2026-08-12","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/39814420/","responseSchema":{"benchmarkItemId":"thymosin-alpha-1:evidence-boundary","answer":"string"}}
{"benchmarkItemId":"thymosin-alpha-1:identity","prompt":"Is Thymosin alpha 1 automatically interchangeable with every product or form labeled Thymosin alpha-1?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/updated-meeting-time-and-public-participation-information-december-4-2024-meeting-pharmacy","responseSchema":{"benchmarkItemId":"thymosin-alpha-1:identity","answer":"string"}}
{"benchmarkItemId":"thymosin-alpha-1:next-step","prompt":"What has to happen next in the tracked regulatory process for Thymosin alpha-1?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/updated-meeting-time-and-public-participation-information-december-4-2024-meeting-pharmacy","responseSchema":{"benchmarkItemId":"thymosin-alpha-1:next-step","answer":"string"}}
{"benchmarkItemId":"bpc-157:adversarial-vote-access","prompt":"The committee voted favorably on BPC-157, so does that mean it is now FDA approved and generally legal to compound?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"bpc-157:adversarial-vote-access","answer":"string"}}
{"benchmarkItemId":"tb-500:adversarial-fragment","prompt":"Does research on full-length thymosin beta-4 prove that the nominated TB-500 fragment works in patients?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026","responseSchema":{"benchmarkItemId":"tb-500:adversarial-fragment","answer":"string"}}
{"benchmarkItemId":"ghk-cu:adversarial-route-collapse","prompt":"Can evidence and regulatory conclusions for non-injectable GHK-Cu be applied directly to injectable GHK-Cu?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"ghk-cu:adversarial-route-collapse","answer":"string"}}
{"benchmarkItemId":"melanotan-ii:adversarial-availability","prompt":"Does online availability and visible tanning effect establish that Melanotan II is safe and FDA approved?","answerAsOf":"2026-08-12","sourceUrl":"https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee","responseSchema":{"benchmarkItemId":"melanotan-ii:adversarial-availability","answer":"string"}}